Dublin, May 18, 2023 (GLOBE NEWSWIRE) -- The "Biodefense Market - Global Industry Analysis (2019 - 2022), Growth Trends, and Market Forecast (2023 - 2030)" report has been added to ResearchAndMarkets.com's offering.
The confluence of rising concerns about biothreats and the emergence of infectious diseases has created a demand for biodefense products and services. Recognising this need, government authorities worldwide are making significant investments in biodefense research, development, and procurement programs to ensure public health preparedness and enhance national security.
Such a scenario is also influencing strategic partnerships among key players in the biodefense market. These collaborations aim to enhance their capabilities, expand their product portfolios, and strengthen their market presence. Furthermore, the advances in biotechnology, genomics, and proteomics are facilitating the development of innovative biodefense products, and services with enhanced efficacy, specificity, and rapidity.
Additionally, the increasing public awareness of the potential impact of biothreats on health and national security is accelerating efforts to develop biodefense measures. In its latest report, the analyst foresees the growth trajectory for the global biodefense market. Registering a revenue worth US$14.8 Bn in 2022, the market is slated for a substantial CAGR of 6.3% over the forecast period and is expected to reach a whopping US$24.5 Bn by 2030.
Key Insights and Trends Across Biodefense Market
- Anthrax category to emerge as a leading product type, accounting for a lion share (30%) of the market
- Military segment to establish itself as a frontrunner in the global biodefense market, exhibiting a robust CAGR of 6.2%
- North America to sustain market dominance owing to favourable federal funding, reaching a staggering US$20.8 billion by the end of 2030
Infectious Diseases Pose Mounting Threat to Global Health, Spurring Explosive Growth Across Biodefense Market
Over recent years, the risk of infectious diseases, due to the accidental or deliberate release of chemical, biological, radiological, or nuclear (CBRN) agents, has increased. This in turn has prompted biodefense firms to develop sophisticated diagnostic tools that can detect a wide array of infectious agents, including viruses, bacteria, and fungi. Companies are also investing in research and development to create innovative therapeutics and vaccines. Currently, there is a range of prophylactic, therapeutic, and diagnostic products available for significant biological, chemical and radiation threats. In light of these circumstances, the global biodefense market is projected to gain substantial momentum in the upcoming years.
Advanced Healthcare Infrastructure Puts North America at the Forefront of Global Biodefense Market
North America is well-positioned to attain a distinct advantage in the global biodefense market. This is primarily attributable to the strong and effective strategies of the United States government. Besides, North America has made significant investments in research and development activities and procurement programs. Apart from this, the region also boasts a well-developed healthcare infrastructure with modern diagnostic and treatment facilities that enable rapid detection and response to biodefense. Such trends are sowing the seed of sustainable growth across North America's biodefense market.
Prominent Market Players
Some of the key players in the global biodefense market include Nanotherapeutics, Inc., SIGA Technologies, Inc., Emergent BioSolutions, Inc., Altimmune, Inc., Bavarian Nordic A/S, Statera Biopharma, Inc., GSK plc. Sanofi Pasteur, Dynavax Technologies Corporation, Xoma Corporation, Meridian Medical Technologies, NightHawk Biosciences, Inc., Dynport Vaccine Company LLC, LLC, and Soligenix.
Key Topics Covered:
1. Executive Summary
2. Market Overview
3. Global Biodefense Market Outlook, 2019 - 2030
3.1. Global Biodefense Market Outlook, By Product Type, 2019 - 2030
3.1.1. Key Highlights
3.1.2. Global Biodefense Market Outlook, by Product Type, Value (US$ Million), 2019 - 2030
3.1.2.1. Anthrax
3.1.2.2. Smallpox
3.1.2.3. Botulism
3.1.2.4. Chemical
3.1.2.5. Radiation/Nuclear
3.1.2.6. Others
3.1.3. Global Biodefense Market Share and BPS Analysis, by Product Type, Value, 2023 and 2030
3.1.4. Global Biodefense Market Attractiveness Analysis, by Product Type, Value, 2023 - 2030
3.2. Global Biodefense Market Outlook, By End Use Type, 2019 - 2030
3.2.1. Key Highlights
3.2.2. Global Biodefense Market Outlook, by End Use Type, Value (US$ Million), 2019 - 2030
3.2.2.1. Military
3.2.2.2. Civil
3.2.2.3. Research Institutes
3.2.3. Global Biodefense Market Share and BPS Analysis, by End Use Type, Value, 2023 and 2030
3.2.4. Global Biodefense Market Attractiveness Analysis, by End Use Type, Value, 2023 - 2030
3.3. Global Biodefense Market Outlook, By Region, 2019 - 2030
3.3.1. Key Highlights
3.3.2. Global Biodefense Market Outlook, by Region, Value (US$ Million), 2019 - 2030
3.3.2.1. North America
3.3.2.2. Europe
3.3.2.3. Asia Pacific
3.3.2.4. Rest of the World
3.3.3. Global Biodefense Market Share and BPS Analysis, by Region, Value, 2023 and 2030
3.3.4. Global Biodefense Market Attractiveness Analysis, by Region, Value, 2023 - 2030
4. North America Biodefense Market Outlook, 2019 - 2030
5. Europe Biodefense Market Outlook, 2019 - 2030
6. Asia Pacific Biodefense Market Outlook, 2019 - 2030
7. Rest of the World Biodefense Market Outlook, 2019 - 2030
8. Competitive Landscape
9. Appendix
A selection of companies mentioned in this report includes
- Emergent Biosolutions, Inc.
- SIGA Technologies, Inc.
- Bavarian Nordik A/S
- GSK plc
- Sanofi Pasteur
- NightHawk Biosciences (Elysus Therapeutics, Inc.)
- Soligenix
- Arbutus Biopharma Corporation
- Altimmune
- Meridian Medical Technologies LL
For more information about this report visit https://www.researchandmarkets.com/r/chopke
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
